LTPLFLTR PHARMA LTD.

About LTR PHARMA LTD. (LTPLF)

LTR PHARMA LTD. (LTPLF) is a N/A company headquartered in Brisbane, QL, Australia whose shares trade over-the-counter on the Pink tier.

LTR Pharma Limited, a biopharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED.

LTPLF key facts

Ticker symbol

LTPLF

Market tier

Pink

Headquarters

Brisbane, QL, Australia

Shares outstanding

139,420,252

Reporting standard

International Reporting: ASX - Australian Securities Exchange

Audit status

Audited

Fiscal year end

6/30

Explore more: Pink stocks · OTC stocks starting with L